Abiopharma

Cypherpunk Purchases Additional $18 Million of ZEC, Bringing Total Network Percentage to 1.43%

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2025 THIRD QUARTER FINANCIAL RESULTS

EDAP to Present at Piper Sandler 37th Annual Healthcare Conference

Merck’s WINREVAIR™ (sotatercept-csrk) Met Primary Endpoint in Phase 2 CADENCE Study in Adults With Combined Post- and Precapillary Pulmonary Hypertension (CpcPH) due to Heart Failure With Preserved Ejection Fraction (HFpEF)

Investor Alert: Robbins LLP Informs Investors of the Perrigo Company Plc Class Action

Medtronic reports strong second quarter fiscal 2026 financial results, enterprise growth drivers accelerate momentum

Bio-Techne Licenses AI-Designed NovoBody™ Duo Molecules from Monod Bio to Expand Recombinant Protein Portfolio

Rockwell Medical Appoints Joe Dawson to the Companys Board of Directors

MediciNova Appoints Dr. Christopher Breder, MD, PhD as Clinical and Regulatory Advisor

Smith+Nephew PLC Notification